Wuxi Beta Completes ￥10M Series B Financing

(VCBeat) Mar. 20, 2021 -- Recently, Wuxi Beta Pharmatech Co., Ltd. ("Wuxi Beita"), which is located in Jiangyin High-tech Zone, Jiangsu Province,  has raised tens of millions of yuan in Serie B financing led by Fortune Link. The funds raised will be mainly used for technology research, new product development, industrialization construction and localization and internationalization of the existing C-14 labeling technology.

Wuxi Beta was founded in Jiangyin High-tech Zone in November 2008 by Dr. Li Gang, who won the second prize of the National Science and Technology Progress Award. As a high-tech private enterprise spanning several important fields such as "nuclear technology application + isotope labeling and tracing + biomedicine + new drug R&D outsourcing", Wuxi Beta has been deeply engaged in the R&D and industrialization of C14, C13, and other isotope labeling products.

Wuxi Beta has established the "Nobel Research Institute", "Academician Workstation" and "Isotope Labeling Engineering Technology Research Center" and other R&D institutions. After more than ten years of hard work, the company has accumulated solid strength in isotope technology and created five "gold standards" of products and technologies in the field of medicine and medical treatment. Wuxi Beta has the most comprehensive technology in the international industry and can provide reliable high-tech services for scientific research institutes and companies.

Wuxi Beta has successfully provided dozens of C-14 and H-3 labeled compounds for pharmaceutical, pesticide and environmental-related companies, and obtained high praise consistently. 

Fortune Link is a famous private equity fund management firm in Shanghai.With more than 20 management teams across China, Fortune Link manages more than 60 funds, including several government guide funds. The total subscribing scale of funds under management is more than 60 billion yuan, and the actual payment scale is more than 30 billion yuan.Its business covers government parent fund, VC fund, PE fund, industry fund, merger and acquisition fund, bailout fund, etc.